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ABSTRACT 
This report describes an experimental system whereby human skin was grafted to 
immunosuppressed mice, thus avoiding the restrictions imposed by the use of human 
subjects or tissue cultures. Grafts remained in good condition for the subsequent life of t he 
animal, as long as eight months. The human skin xenografts were inoculated with an extract 
of verrucae vulgaris, but no warts developed during the period of observation. 
Human epidermis is readily accessible for exper-
imental studies but ethical considerations often 
limit in vivo experimentation. Tissue culture 
methods usually permit only very s hort-term 
investigations. We have attempted to develop an 
experimental system whereby human s kin could be 
grafted to an immunos uppressed experimental 
animal and manipulated without any of the re -
strictions imposed by the use of human subjects or 
tissue cultures. We have previously reported long-
term survival of human skin placed on an exterio-
rized hams ter cheekpourh [lj. Approximately 50 
percent of these human skin grafts survived for at 
least 14 weeks. 
Although the human skin grafts were inoculated 
with an extract of verrucae. no papmomas devel-
oped in the grafts during 14 weeks of observation. 
However, when rabbit skin was grafted and in-
fected with the hope papilloma virus, almost all 
grafts developed papillomas. The failure of human 
skin t.o undergo papillomatous transformation was 
surprising. This fai lure might have been the result 
of a lack of viral infectivity or an insufficiently long 
period of observation. Infectivity of human wart 
virus can only be assessed in man 121 and not in 
tissue cul ture 131. Jn view of the unknown onco-
genic potential of this virus for the induction of 
neoplasms other than verrucae, human inoculation 
is not feasible . A longer period of observation or 
these human s kin grafts was therefore important. 
The purpose of these experiments was to maxi-
mally prolong the survival of human skin grafts 
placed on mice which were chronically immuno-
suppressed with antithymocyte serum (ATS). 
Ra ther than the hamsters used in the previous 
study. mice were employed as hosts because oft he 
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relatively s maller volumes of ATS required and 
subsequent reduced costs [4]. 
MATERIALS A:'<D METHODS 
Skin grafting of mice. C57Bl)6J male mice 4-5 weeks 
old were purchased from the Jackson Laboratory, Bar 
Harbor, Maine. Human s kin grafts were prepared from 
radical mastectomy specimens as previously described 
IL). Freshly excised human skin, 4 x 5 em, was fastened 
with push pins at 4 comers to a corkboard. The skin was 
washed with iO~ ethanol and rinsed with ether. A steril e 
scalpel held parallel to the skin surface was used to slice 
off the split-thickness (0.5 mm) skin grafts. These grafts 
were collected and held in a Petri dish filled with 
Minrmum Essential Medium (Eagle's). The grafts were 
trimmed with a scalpel to a square of 6- 10 mm on an 
edge. 
To prepare a graft bed in mtce, the animals were 
anesthetized with embutal and the fur was clipped. 
The skin was washed with 70% ethanol and blotted dry 
with a sterile gauze pad. With curved scissors and a 
toothed forceps, the s kin was elevated and snipped off to 
create a defect which closely fit the graft. The underlying 
panniculus carnosus and its rich blood supply were 
carefully preserved. The graft was gently pressed into the 
bed and excess lluid blotted off with sterile gauze. 
DressingS consisted of a 1-cm square of 2 thicknesses of 
Adaptic gauze (Johnson & Johnson, New Brunswick, 
N. J.) and a covering of 2 wrappings of Dermicel First Aid 
Tape (Johnson & Johnson) around the thorax. One week 
after grafting, the dressingS were removed and the grafts 
inspected. 
Antily mphocyte serum. ATS was purchased from 
Microbiological Agsociates, Bethesda. Md. This ATS was 
pre\·iously assayed by the manufacturer and produced a 
doubling of mean survival time of skin allografts across 
the H-2 locus in mice. We administered the ATS at a 
dosage of 0.25 ml (intraperitoneal! given on day 0, -.- 1, 
+3. +5. + 7. and three times each week thereafter. After 
inoculation with wart extract, the ATS injections were 
reduced w two times per week until the death of the 
animal. All animals were necropsied and tissues, includ-
ing grafts, studied microscopically. 
Preparation of wart extracts and inoculation of mice. 
Parings were obtained from two untreated plantar warts. 
Wart (2.0 gm) tissue was minced in 2.0 ml phosphate 
buffered saline (PBS ). pH 7.-1, and homogenized in a 
glass and teflon apparatus at o~ • C. Paniculate material 
was pelleted by low-speed centrifugation. 50 pi of super-
natant solution were immediatelv inoculated into the 
xenografts of nine mice and the -grafts were escarified 
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wit h a 30-gauge needle Mice were hand-held until the 
inoculum d ried. Four mice were inoculated at six weeks 
following grafting, and five m1ce were inoculated three 
weeks following gralling. After moculation, the remain -
ing wart extract was centnfuged at 17-1.000 ' 11 for 60 
mm, and the pellet wa~ resuspended 111 0.1 ml PBS. This 
matenal was exarnmed for the presence of virus m the 
electron microst'ope after negative stammg with I'> 
pho~photnngstic acid 15). 
ItEM l.TS 
Fourteen mtce recei,ed human spltt-thtckness 
skin gralts. In one group of six mice. the grafts ''ere 
6 7 mm in diameter, and all the !{rafts survived. A 
~econd group of ei~ht mice recel\ ed lar!{er grafts 
8-10 m m in dtameter, and in lc1ur of these animal~ 
the !{rafts were sloughed or rejected within nne 
week. The failure of these !{raft;. to .. take .. could he 
the result of mechanical detachment or im-
munologic rejection. Since the dressings were not 
re moved until the sevent h da). no prior observa-
tions were made and the question cannot be 
resolved. By three week~ all ,-,able xenogralt l:i were 
reduced in size to apprnximatelv I mm tFig. IJ, 
and the 4-mm grafts ~ur\'lved wtthout further ~11e 
reduction until the death of the mouse. Two rntce 
with intact xenngratts succumbed within :lO days, 
but the other eight mice lived from three months w 
over eight months ! Ftg. :?J. 
:\ine mice \H' re inoculated wtth a freshly pre-
pared extract ol wan tissue and oh,ened unttl ill 
or near death, at which time the animals were 
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F1c:. :3: Hematoxylin and eosin stamed Rect inn at the edge of a xenograf t 27 days after grafting. Human s kin is on the 
left and mouse skin on the right. Original magnification · 200. 
sacrificed and ll~~ues histologically examined. The 
inoculum contained whole vi rions and clumped 
dehri:; induding bacterial lorms. The graft ~ite 
(F ig. :H showed a transit ion from hair bearing 
mouse epidermis only se\'eral rE'll~ thick to epider-
mis closelv resembling nnrrnal human skin. excE'p t 
for a parakernlotit· corneum and ~ome effacement 
of rete ridge!-.. Collagen fiber .. helow the h u man 
epidermis were 1 hic·ker and more dense!~ organi7E'd 
than in mouse skin . Xo gross or hi!;tologic e,·idence 
of wart format 1or1 \ \ 'B!i observed. l\l ononurlrar 
infiltrate!'. were not evident. M icro,copie examinu-
tion of 1 he viscera revealed only fiJcal atelectasis 
and pneumonitis. There were reduced num hers of 
lymphocyte>. in the s pl t>n ic parenchyma. 
Thi>. report del'crihes the prolonged survi\'al of 
human skin xenografts for periods of time up to 
over eight months on ATS-treated mice. Others 
have reported the survival ol human split-thick · 
ness xenografts for l ivf' '' eeks in antilymphocyte -
treated mice I.J 1. The grafts in (IUr experiments 
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remained in good condition for the life of the 
animal, afford ing a small but easily observed and 
manipulated area of human skin The lack of 
mononuclear leukocytic infiltration suggests effi-
cient suppression of cell-mediated immunity. 
However, the contracture of these grafts could be 
the result of chronic rejection, possibly on an 
antibody basis since antithymocyte serum does not 
completely abolish antibody formation 16). 
The failure of the grafts to form verrucae may be 
secondary to the irregular infectivity and pro-
longed latency noted with the inoculation of wart 
virus in human volunteers [2]. We attempted to 
prepare an inoculum with a minimum of experi-
mental manipulations which might inactivate the 
vi rus, but there is no way short of human inocula-
tion to assay infectivity. An intriguing possibility 
accounting for the negative results is that the ATS 
might include neutralizing antibody to the human 
wa rt virus. Although mice do not encounter this 
vi rus spontaneously, it could be cross;- reactive with 
other murine virions. This possibility cannot be 
d irectly tested in the absence of an infectivtty 
assay for h uman wart virus. 
In summary, some human skin grafts placed on 
AT -treated mice survived at least eight months. 
Although we have been unable to produce verrucae 
on the graft site, the experimental technique is 
simple and we commend it to investigators inter-
ested in similar applicationb. 
REFERE. CES 
1. Kreider JW, Haft HM. Roode PB: Growth of human 
skin on the hamster ,J Invest Dermatol 57:66-71. 
1971 
2. Rowson KEK, Mahy BWJ: Human papova (wart) 
virus. Bacteriol Rev 31: I 10 131, 1967 
3. Butel JS: Studtes with human papilloma vtrus mod 
eled after known papovavirus systems . . J Nat! Can-
cer lnst 48:285- 299, 19i2 
4. Lance EM. Medawar PB: Surv1val of~kin heterografts 
under treatment with anti-lymphocyte berum. Lan-
cet 1:1174 1176, 1968 
5. Noyes WF: Structure of the human wart virus. Virol-
ogy 23:65 72, 1964 
6. Barth RF, Southworth J : Stud1es on heterologous 
antilymphocyte and antithymocyte sera II. Effects 
on cellular antibody production dunng the early 
primary and secondary immune response of mice to 
sheep erythrocytes. J l mmunol 101:1283 1290, 1968 
